. Corrigendum to "Neuroprotective effects of ginsenoside Rg1 through the Wnt/β-catenin signaling pathway in both in vivo and in vitro models of Parkinson's disease" [Neuropharmacology 101 (2016) 480-489 NEUROPHARM-D-15-00626]. Neuropharmacology. 2025 Mar 1;265:110260. Epub 2024 Dec 9 PubMed. Corrected paper.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.